These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29803376)

  • 1. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Response Assessed by Contrast-Enhanced Ultrasound in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
    Dong T
    Ultrasound Q; 2018 Jun; 34(2):84-87. PubMed ID: 29420367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
    Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
    Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
    Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
    Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
    Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative parameters of contrast-enhanced ultrasound in breast invasive ductal carcinoma: The correlation with pathological prognostic factors.
    Ji CL; Li XL; He YP; Li DD; Gu XG; Xu HX
    Clin Hemorheol Microcirc; 2017; 66(4):333-345. PubMed ID: 28387663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
    Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
    Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
    Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
    Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki-67 and Ultrasound Features.
    Liu Q; Tang L; Chen M
    J Ultrasound Med; 2022 Sep; 41(9):2191-2201. PubMed ID: 34888900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
    Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
    Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos.
    Zhang Q; Yuan C; Dai W; Tang L; Shi J; Li Z; Chen M
    Phys Med; 2017 Jul; 39():156-163. PubMed ID: 28690116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging.
    Kaise H; Shimizu F; Akazawa K; Hasegawa Y; Horiguchi J; Miura D; Kohno N; Ishikawa T
    J Surg Res; 2018 May; 225():175-180. PubMed ID: 29605029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Han X; Jin S; Yang H; Zhang J; Huang Z; Han J; He C; Guo H; Yang Y; Shan M; Zhang G
    Br J Radiol; 2021 Sep; 94(1125):20210520. PubMed ID: 34415197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.